“CBRAM technology unleashes a new paradigm of performance and ultra-low energy use, enabling a wide range of applications, from wearable devices to smartphones,” says GloFo’s Mike Hogan.
CBRAM’s low power consumption, high read/write speeds, reduced manufacturing costs and tolerance for harsh environments make it suitable for consumer, medical, and select industrial applications.
In 2020, GloFo entered into a licensing agreement with Dialog Semiconductor, which was acquired by Renesas in 2021, to offer its CBRAM technology as an embedded NVM option.
Today, CBRAM is being qualified on the company’s 22FDX platform, with plans to extend it to other platforms.
